Skip to main content

CV Sciences, Inc.

corporate_fare Company Profile

CV Sciences, Inc.

CVSI·OTC·Life Sciences·CIK 0001510964

CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The company sells its hemp extracts and other natural ingredients and products through both business-to-business (B2B) and business-to-consumer (B2C) channels. Its +PlusCBD™ branded products are sold at select retail locations across the U.S. and are the top-selling brands of hemp extracts in the natural products market, according to SPINS. +PlusCBD™ product benefits in healthy people are supported by human clinical research data and three published clinical case studies on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to achieve self-affirmed Generally Recognized as Safe (GRAS) status. On December 7, 2023, CV Sciences acquired Cultured Foods Sp. z.o.o., a leading European manufacturer and distributor of plant-based protein products, making it a wholly owned subsidiary. In January 2025, the company launched Lunar Fox™, a brand focused on distributing plant-based products in the U.S. market. The Cultured Foods™ and Lunar Fox™ brands offer a variety of 100% plant-based food products. In May 2024, CV Sciences acquired Elevated Softgels, LLC, a Colorado-based manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. In August 2024, the company engaged Maxim Group, LLC as a non-exclusive financial advisor and investment banker.

CV Sciences, Inc. (OTC:CVSI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 12 items for CVSI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-09, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CVSI spans 4, 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • 10% Owner Charles Cheever Buys $114.8K of CVSI Stock at $0.02
  • CV Sciences Q2 Revenue Drops 17.5%, Going Concern Warning Reiterated
  • Shareholders Reject Reverse Stock Split Proposal Amidst Going Concern Warning
  • Q1 Revenue Drops 11.4%, Net Loss Widens Amid Going Concern & Major Dilution
  • CV Sciences Q1 Revenue Plunges 11% to $3.2M Amid Regulatory Headwinds

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$13.79M
Net Income
-$958K
Diluted EPS
-$0.01
Op. Cash Flow
-$407K
Free Cash Flow
-$516K
Gross Profit
$6.75M
Operating Income
-$470K
Cash & Equivalents
$278K
Total Debt
$1.65M
Debt / Equity
1.12×
Net Margin
-6.9%
Shares Outstanding
184.26M sh
Source: 10-K · filed 2026-03-26 · accession 0001193125-26-126598

Dilution Risk

Low risk

Filing-implied dilution signals for CVSI, detected from its recent SEC filings · based on capital-structure filings through 2026-03-26.

Going Concern Warning Issued · Critical Regulatory Changes for Hemp Products

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$0.0168 -0.00% today
52-week range · as of 2026-09-09 $0.0145 – $0.10
Market cap
$3.79M
Volume
1.2M (2.3× avg)
3-mo avg 520.6K
Live data · 2026-09-12 15:55 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CVSI - Latest Insights

CVSI
Sep 09, 2026, 6:43 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.01898
Real-time Price: $0.0168 info
Change: -$0.00218 (-11%) info
Market Cap: $3.794M info
CVSI
Aug 13, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.02535
Real-time Price: $0.0168 info
Change: -$0.00855 (-34%) info
Market Cap: $3.794M info
CVSI
Jun 04, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.02914
Real-time Price: $0.0168 info
Change: -$0.01234 (-42%) info
Market Cap: $3.794M info
CVSI
May 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.0301
Real-time Price: $0.0168 info
Change: -$0.0133 (-44%) info
Market Cap: $3.794M info
CVSI
May 14, 2026, 4:08 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.03075
Real-time Price: $0.0168 info
Change: -$0.01395 (-45%) info
Market Cap: $3.794M info
CVSI
May 14, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.03075
Real-time Price: $0.0168 info
Change: -$0.01395 (-45%) info
Market Cap: $3.794M info
CVSI
Apr 14, 2026, 9:15 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.03073
Real-time Price: $0.0168 info
Change: -$0.01393 (-45%) info
Market Cap: $3.794M info
CVSI
Apr 10, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.03609
Real-time Price: $0.0168 info
Change: -$0.01929 (-53%) info
Market Cap: $3.794M info
CVSI
Mar 26, 2026, 5:14 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.033
Real-time Price: $0.0168 info
Change: -$0.0162 (-49%) info
Market Cap: $3.794M info
CVSI
Mar 26, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.033
Real-time Price: $0.0168 info
Change: -$0.0162 (-49%) info
Market Cap: $3.794M info
CVSI
Mar 10, 2026, 5:16 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0456
Real-time Price: $0.0168 info
Change: -$0.0288 (-63%) info
Market Cap: $3.794M info
CVSI
Mar 10, 2026, 5:00 PM EDT
Source: Acceswire
Importance Score:
8
Price at Filing: $0.0456
Real-time Price: $0.0168 info
Change: -$0.0288 (-63%) info
Market Cap: $3.794M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets